Functional health and white matter hyperintensities as effect modifiers of blood pressure-lowering on cognitive function and vascular events in older Secondary Prevention of Small Subcortical Strokes trial participants.

Blum, Manuel R.; Scherzer, Rebecca; Ikeme, Jesse C; Benavente, Oscar R; McClure, Leslie A; Peralta, Carmen A; Odden, Michelle C (2020). Functional health and white matter hyperintensities as effect modifiers of blood pressure-lowering on cognitive function and vascular events in older Secondary Prevention of Small Subcortical Strokes trial participants. Journal of hypertension, 38(8), pp. 1578-1585. Lippincott Williams & Wilkins 10.1097/HJH.0000000000002440

Preview	Text Blum JHypertens 2020_AAM.pdf - Accepted Version Available under License Publisher holds Copyright. Download (722kB) | Preview
	Text Blum JHypertens 2020.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (5MB) | Request a copy

OBJECTIVE

To determine whether cerebral small vessel disease or disability modify the effect of SBP treatment on cognitive and vascular outcomes in older patients with recent lacunar stroke.

METHODS

Participants aged at least 65 years of the Secondary Prevention of Small Subcortical Strokes Trial were randomized to a higher (130-149 mmHg) or lower (<130 mmHg) SBP target. The primary outcome was change in cognitive function (Cognitive Abilities Screening Instrument); secondary outcomes were incident mild cognitive impairment, stroke, major vascular events (all-stroke, myocardial infarction), and all-cause death. Results were stratified by severity of white matter hyperintensities (WMH; none/mild, moderate, severe) on baseline MRI, and by disability (no vs. at least one limitation in activities of daily living).

RESULTS

One thousand, two hundred and sixty-three participants (mean age 73.8 ± 5.9 years, 40% women) were included. Participants with severe WMH or disability had worse cognitive function at baseline and after a mean follow-up of 3.9 years. No significant interactions existed between treatment group and effect modifiers (WMH, disability) for change in cognitive function (P for interaction 0.42 and 0.66, respectively). A lower SBP target appeared more beneficial among those with worse WMH burden for vascular outcomes (P for interaction = 0.01 for stroke and 0.03 for major vascular events).

CONCLUSION

There was no difference in the effect of lowering SBP to less than 130 mmHg on cognitive function by cerebral small vessel disease or disability among older adults with a history of lacunar stroke. Those with evidence of small vessel disease may derive greater benefit from lower SBP on prevention of subsequent vascular events.

TRIAL REGISTRATION

Clinicaltrials.gov Identifier: NCT00059306.

Interest & Impact

Downloads

252 since deposited on 12 May 2020
97 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item